BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20530548)

  • 1. HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans.
    Iwamoto R; Mine N; Kawaguchi T; Minami S; Saeki K; Mekada E
    Development; 2010 Jul; 137(13):2205-14. PubMed ID: 20530548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HB-EGF decelerates cell proliferation synergistically with TGFalpha in perinatal distal lung development.
    Minami S; Iwamoto R; Mekada E
    Dev Dyn; 2008 Jan; 237(1):247-58. PubMed ID: 18069687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors.
    Camenisch TD; Schroeder JA; Bradley J; Klewer SE; McDonald JA
    Nat Med; 2002 Aug; 8(8):850-5. PubMed ID: 12134143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation.
    Nanba D; Kinugasa Y; Morimoto C; Koizumi M; Yamamura H; Takahashi K; Takakura N; Mekada E; Hashimoto K; Higashiyama S
    Biochem Biophys Res Commun; 2006 Nov; 350(2):315-21. PubMed ID: 17010937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF promotes epithelial cell migration in eyelid development.
    Mine N; Iwamoto R; Mekada E
    Development; 2005 Oct; 132(19):4317-26. PubMed ID: 16141218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscleblind-like 1 is required for normal heart valve development in vivo.
    Coram RJ; Stillwagon SJ; Guggilam A; Jenkins MW; Swanson MS; Ladd AN
    BMC Dev Biol; 2015 Oct; 15():36. PubMed ID: 26472242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis.
    Iwamoto R; Mine N; Mizushima H; Mekada E
    J Cell Sci; 2017 Apr; 130(7):1321-1332. PubMed ID: 28232522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans.
    Chu CL; Goerges AL; Nugent MA
    Biochemistry; 2005 Sep; 44(36):12203-13. PubMed ID: 16142919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.
    Jackson LF; Qiu TH; Sunnarborg SW; Chang A; Zhang C; Patterson C; Lee DC
    EMBO J; 2003 Jun; 22(11):2704-16. PubMed ID: 12773386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the endocardial-to-mesenchymal transformation of heart valve development by collagen gel culture assay.
    Xiong Y; Zhou B; Chang CP
    Methods Mol Biol; 2012; 843():101-9. PubMed ID: 22222525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
    Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
    J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis.
    Cai X; Zhang W; Hu J; Zhang L; Sultana N; Wu B; Cai W; Zhou B; Cai CL
    Development; 2013 Aug; 140(15):3176-87. PubMed ID: 23824573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of heparan sulfate proteoglycans in cell signaling during development.
    Lin X
    Development; 2004 Dec; 131(24):6009-21. PubMed ID: 15563523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.
    Prince RN; Schreiter ER; Zou P; Wiley HS; Ting AY; Lee RT; Lauffenburger DA
    J Cell Sci; 2010 Jul; 123(Pt 13):2308-18. PubMed ID: 20530570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
    Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
    J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice.
    Sugi Y; Yamamura H; Okagawa H; Markwald RR
    Dev Biol; 2004 May; 269(2):505-18. PubMed ID: 15110716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
    Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
    Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.